Michael Mutz
27Patents
4h-index
35Co-inventors
63Inventor score
Filing activity: Jun 10, 1976 → Sep 20, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6194181A | Fermentative preparation process for and crystal forms of cytostatics | Chemistry; Metallurgy | 55 | Expired |
| US6380227B1 | Fermentative preparation process for and crystal forms of cytostatics | Chemistry; Metallurgy | 26 | Expired |
| US4078014A | Composition of polyamide, polyethylene ionomer copolymer | Chemistry; Metallurgy | 21 | Expired |
| US4217430A | Graft copolymer of neutralized acid copolymer trunk and polyamide oligomeric branches and method for making such copolymer | Emerging Cross-Sectional Technologies | 21 | Expired |
| US8530522B2 | Organic compounds | Chemistry; Metallurgy | 4 | Active |
| US7893076B2 | Crystalline form F of Imatinib mesylate | Chemistry; Metallurgy | 2 | Active |
| US7879860B2 | Delta and epsilon crystal forms of Imatinib mesylate | Human Necessities | 1 | Active |
| US6656711B2 | Fermentative preparation process for and crystal forms of cytostatics | Chemistry; Metallurgy | 1 | Expired |
| US8513256B2 | Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide | Human Necessities | 1 | Active |
| US8710216B2 | Organic compounds | Human Necessities | 0 | Active |
| US8349852B2 | Quinazolinone derivatives useful as vanilloid antagonists | Human Necessities | 0 | Active |
| US8178566B2 | Crystal form of epothilone B and use in pharmaceutical compositions | Human Necessities | 0 | Active |
| US10919887B2 | Salts and solid forms of a monobactam antibiotic | Emerging Cross-Sectional Technologies | 0 | Active |
| US8163747B2 | Acid addition salts, hydrates and polymorphs of 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide and formulations comprising these forms | Chemistry; Metallurgy | 0 | Active |
| US8846706B2 | Crystalline form K of imatinib mesylate | Chemistry; Metallurgy | 0 | Active |
| US8198435B2 | Crystal form of N-benzoyl-staurosporine | Human Necessities | 0 | Active |
| US8153672B2 | Polymorphic forms of deferasirox (ICL670A) | Human Necessities | 0 | Active |
| US8592440B2 | Crystalline form I of imatinib mesylate | Chemistry; Metallurgy | 0 | Active |
| US7101702B2 | Fermentative preparation process for and crystal forms of cytostatics | Chemistry; Metallurgy | 0 | Expired |
| US7683048B2 | Polymorphis of a known thiophenecarboxylic acid dodecahydrocyclopenta (a) phenanthrenyl ester | Chemistry; Metallurgy | 0 | Active |
| US8633213B2 | Crystalline form F of imatinib mesylate | Chemistry; Metallurgy | 0 | Active |
| US8198289B2 | Crystal form H imatinib mesylate for pharmaceutical use | Chemistry; Metallurgy | 0 | Active |
| US8507515B2 | Crystalline form G of imatinib mesylate | Chemistry; Metallurgy | 0 | Active |
| US8436030B2 | Polymorphic forms of deferasirox (ICL670A) | Human Necessities | 0 | Active |
| US8946272B2 | Plymorphic forms of deferasirox (ICL670A) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.